The epilepsy treatment is now approved as an add-on therapy for patients aged ≥ 2 years, following an appeal against NICE’s initial rejection.

A new treatment option has become available for severe epilepsy: fenfluramine, which is now available on the NHS ...

Hundreds of children in England with a rare and severe form of epilepsy are set to benefit from a new drug being rolled out ...

People with a rare form of epilepsy in England will now have a new treatment option to try following approval by NICE.

The drug is the first non-cannabinoid option for patients with LGS and an alternative to Jazz Pharma's Epidyolex (cannabidiol ...

In a U-turn for the UK health technology assessor, the National Institute for Health and Care Excellence (NICE) has today ...

"For children and families living with Lennox-Gastaut syndrome, every day can be challenging, facing unpredictable and life-limiting seizures, and this new treatment option on the NHS will now ...

Children over the age of two and adults with Lennox-Gastaut syndrome (LGS) in Scotland can now be prescribed the ...

Fenfluramine has been recommended by the National Institute for Health and Care Excellence (Nice) for patients aged two and over with Lennox–Gastaut syndrome (LGS). It is the first non-cannabis ...

Researchers at Baylor College of Medicine, the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) at Texas ...